Skip to content

Effect of an Innovative BIO Formula Intake on Infant Growth and Tolerance From 0 to 6 Months

Evaluation of an Innovative BIO Formula Based on a New Whey Extraction Process on the Growth and Tolerance of Infants From 0 to 6 Months.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03936257
Acronym
TRUEGREEN
Enrollment
100
Registered
2019-05-03
Start date
2018-10-30
Completion date
2021-12-30
Last updated
2022-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Development

Brief summary

From birth to 5 months, milk is the essential and unique food of the newborn. The French National Nutrition Program (PNNS) recommends exclusive breastfeeding up to 6 months and at least 4 months for a healthy benefit. However, only 36% of infants 0-6 months of age are exclusively breastfed worldwide. Some mothers choose to give infant formula to their baby in the first few months of life. This decision may be a personal choice or be imposed by pathophysiological situations. The nutritional requirements of the infant are specific, which implies adequate nutrition. Infant formulas and follow-up formulas are therefore complex products, specially developed for a group of vulnerable consumers. In fact, the compositional and information requirements for infant formula are highly regulated. This study, defined as a pilot study, proposes to evaluate the innovative TrueGreen BIO infant formula based on a new whey extraction method on the growth and tolerance of infants from 0 to 6 months compared to the conventional BIO infant formula. As no growth and tolerance data are currently available for this new TrueGreen BIO formula, this study aims to determine them.

Interventions

OTHERBreastfeeding

Infants were breastfed during 3 months minimum. Data on growth and tolerance were collected. 10 out of 40 infants take a blood test to metabolome analysis

OTHERConventional BIO Infant formula

Infant were fed during 6 months with a conventional BIO infant formula. Data on growth and tolerance were collected. 10 out of 40 infants take a blood test to metabolome analysis

OTHERTrueGreen BIO infant formula

Infant were fed during 6 months with the TrueGreen BIO infant formula. Data on growth and tolerance were collected. 10 out of 40 infants take a blood test to metabolome analysis

Sponsors

Sodiaal International
CollaboratorINDUSTRY
Institut Pasteur de Lille
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
1 Days to 21 Days
Healthy volunteers
Yes

Inclusion criteria

* 0 to 3 weeks * Child followed by a general practitioner or pediatrician * Informed consent form signed by the legal representatives of the subject * Commitment of legal representatives to follow the constraints generated by the study * Insured

Exclusion criteria

* Infant born prematurely before 37 weeks of amenorrhea * Child allergic to cow's milk proteins * Pathological pregnancy (hypertension, infection, gestational diabetes, etc.); * Chronic or acute illness (metabolic or neuromuscular diseases, epilepsy, asthma, diabetes, digestive, renal, cardiac or haematological diseases); * Incapacity for the legal representative(s) to understand or adhere to the protocol * Subject involved in another clinical study or in an exclusion period from another study * Legal representatives deprived of liberty * Legal representatives in a position to judicial protection * Weight of the subject according to age and sex, not included between the 3rd and the 97th percentile of the WHO Child Growth Standards * Subject height according to age and sex, not between the 3rd and the 97th percentile of the WHO Child Growth Standards * BMI of the subject according to age and sex, not included between the 3rd and the 97th percentile of the WHO Child Growth Standards * Head circumference of the subject according to age and sex, not included between the 3rd and the 97th percentile of the WHO (World Health Organization) Child Growth Standards * The investigator considers that the state of health or the concomitant treatments are not compatible with the good progress of the clinical study.

Design outcomes

Primary

MeasureTime frameDescription
Evolution of growth of infantsfrom 0 to 6 monthsWeight in kilograms

Secondary

MeasureTime frameDescription
Height evolution of infantsfrom 0 to 6 monthsdata in centimeters
BMI evolution of infantsfrom 0 to 6 monthsdata in kg/m²
Head circumference evolution of infantsfrom 0 to 6 monthsdata in centimeters
Number of colic per dayfrom 0 to 6 monthsEvaluation during 3 consecutives days every month.
Total sleep time per dayfrom 0 to 6 monthsTime in hours. Evaluation during 3 consecutive days every month.
Number of regurgitationfrom 0 to 6 monthsEvaluation during 3 consecutive days every month via Vandenplas scale. According to the Vandenplas scale, seven score are considered: 0 0-2 episodes/day 1. ≥3-≤5 of small volume 2. \>5 episodes of \>1 coffee spoon 3. \>5 episodes of half of the feedings in \< half of the feedings 4. Continuous regurgitations of small volumes \>30 min after each feeding 5. Regurgitation of half to complete volume of a feeding in at least half of the feedings 6. Regurgitation of the 'complete feeding' after each feeding The mean of score during 3 days is considered.
Number of wake up per nightfrom 0 to 6 monthsEvaluation during 3 consecutive days every month.
Plasma amino acid profilebetween 3rd and 4th monthMethods : Liquid Chromatography and Tandem Mass Spectrometry (LC / MS / MS) List of amino acids : Taurine, Aspartic acid, Threonine, Serine, Asparagine, Glutamine acid, Glutamine, Glycine, Alanine, Citrulline, Valine, Cystine, Methionine, Isoleucine, Leucine, Tyrosine, Phenylalanine, Beta aminoisobutyric acid, Ornithine, 1-Methyl-Histidine, Histidine, Lysine, 3-methyl-Histidine, Arginine, Hydroxyproline, Proline
Metabolomic analysis from plasma and urine samplesbetween 3rd and 4th monthNon-targeted analysis : evaluation of all small molecules in biological system, such as amino acids, sugars, alcohols, sugar phosphates, amines, fatty acids, polar lipids, hormones and vitamins, as well as specialized metabolites, such as phenolic compounds, flavonoids, monoterpenes, sesquiterpenes, polyketides, alkaloids, including xenobiotics. Methods : Liquid Chromatography and Mass Spectrometry (LC / MS)
Consistency of stoolfrom 0 to 6 monthsEvaluation during 3 consecutive days every month via Bristol scale. According to the bristol scale, seven types of stool are considered: Type 1: Separate hard lumps, like nuts (hard to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft Type 5: Soft blobs with clear cut edges (easy to pass) Type 6: Fluffy pieces with ragged edges, a mushy stool Type 7: Watery, no solid pieces, entirely liquid The mean of stool type during 3 days is considered.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026